

 
 
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
 
Most Trending
VTYX
Ventyx Biosciences Inc.
$8.42
October 26, 2025 12:46 PM
 Login to see Ventyx Biosciences Inc. (VTYX)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to see Ventyx Biosciences Inc. (VTYX)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths

Earnings are forecast to grow
Chart
$3.53 (+138.53%)
$2.53 (+232.81%)
$2.57 (+227.63%)
$2.1 (+300.95%)
VTYX has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

 
VTYX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

VTYX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
VTYX Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
 Login to display
  Login to displayVTYX Earnings
The TTM reflects 12-month period, providing review of VTYX financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is VTYX current stock price?
What are VTYX stock strengths?
What risks are associated with VTYX stock?
When is VTYX next earnings report?
What is VTYX market cap and volume?
What is VTYX's current Stock IQ?
Should I buy VTYX stock right now?
Is VTYX a Strong Buy right now?
What does a 'Strong Buy' rating mean for VTYX?
What does a 'Strong Sell' rating mean for VTYX?
What factors influence VTYX's Stock IQ?
 
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
VTYX 
 
 
Ventyx Biosciences Inc.
Current Price
$8.42
Stock Insights
Strengths

Earnings are forecast to grow
October 26, 2025 12:46 PM
 Login to unlock Ventyx Biosciences Inc. (VTYX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to unlock Ventyx Biosciences Inc. (VTYX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid  
Chart
$3.53 (+138.53%)
$2.53 (+232.81%)
$2.57 (+227.63%)
$2.1 (+300.95%)
VTYX Analysts Opinion
 
VTYX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

VTYX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
VTYX Street view is extremely bullish and have positive views on the near-term outlook
VTYX has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels.
 Login to display
  Login to displayVTYX Earnings
The TTM data reflects the most recent 12-month period, providing overview of VTYX financial performance.
VTYX Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
VTYX Latest Analysis
Ventyx Biosciences (VTYX) Price Target Increased by 10.39% to 12.39. The average one-year price target for Ventyx Biosciences (NasdaqGS:VTYX) has been revised to $12.39 / share. This is an increase of 10.39% from the prior estimate of $11.22 dated September 27 2025. The price target is an average of many targets provided by an
Wed Oct 29, 2025
Ventyx Biosciences Inc. (VTYX) Discusses Positive Phase II Results of VTX3232 in Obesity and Cardiovascular Risk Factors - Slideshow.
Thu Oct 23, 2025
Ventyx Biosciences stock holds steady as H.C. Wainwright maintains Neutral rating.
Thu Oct 23, 2025
VTYX Surges On Phase 2 Data: VTX3232 Cuts Inflammation Lifts Stock By 83% After Hours . (RTTNews) - Shares of Ventyx Biosciences Inc. (VTYX) skyrocketed over 83% in after-hours trading on Wednesday after the company announced positive results from its Phase 2 study of VTX3232 an oral once-daily NLRP3 inhibitor. The trial targeted patients with obesity and cardiova
Thu Oct 23, 2025
VTYX MEDP INBX Jump After Hours On Key Updates . (RTTNews) - Biotech stocks surged in after-hours trading on Wednesday October 22 led by Ventyx Biosciences which soared over 88% on positive Phase 2 data. A mix of earnings updates clinical news and investor interest lifted several names across the sector including Medpace
Thu Oct 23, 2025
 
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VTYX Stock trends
VTYX Stock performance
VTYX Stock analysis
VTYX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS"). 
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.